Abbott Races To Beat Clock In Patent Brawl With Brazil
Brazil's government and Abbott Laboratories are in last-minute talks to avoid a compulsory license on the U.S. drug maker's AIDS therapy Kaletra, the company said....To view the full article, register now.
Already a subscriber? Click here to view full article